Episode Details
Back to Episodes
Pharmaceutical Executive Daily: FDA Lifts Clinical Hold on NUZ-001
Published 7 months, 2 weeks ago
Description
In today’s Pharmaceutical Executive Daily, we cover the FDA lifting its clinical hold on Neurizon Therapeutics’ lead program Nuz-001, the agency’s export ban on Sun Pharma’s Halol facility, and new insights on how small biotechs can better navigate regulatory and market complexities.